Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Mometasone furoate topical preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate monohydrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate monohydrate 0.05% aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate 1 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate 1 mg/g cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate monohydrate 50mcg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate monohydrate 0.05% scent free aqueous nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate 200micrograms cap activated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate monohydrate (substance) |
Is a |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Formoterol fumarate dihydrate 5microgram + mometasone furoate 200microgram inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Formoterol fumarate dihydrate 5microgram + mometasone furoate 100microgram inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Mometasone furoate monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely mometasone furoate 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 1 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 1 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 1 mg/g cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 1 mg/g cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 50 microgram/actuation nasal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 50 microgram/actuation nasal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 200 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 200 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 400 microgram/actuation powder for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate 400 microgram/actuation powder for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
1 |
Mometasone furoate anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Mometasone furoate (substance) |
Inferred relationship |
Some |
|